Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MT-CO3 pseudogene 13 (MTCO3P13) is classified as a human pseudogene and does not code for a functional protein product[4][5]. It is named in reference to the mitochondrial gene MT-CO3, which encodes cytochrome c oxidase subunit III, a key component of mitochondrial respiratory complex IV; however, MTCO3P13 itself is not involved in mitochondrial function and has no known protein, enzymatic, or receptor activity[4][5]. There is no evidence that MTCO3P13 acts as a drug target, participates in biological pathways, or has any role in disease or therapy. MTCO3P13 is not a functional molecular target, receptor, enzyme, or transporter. It is a pseudogene, lacks biological function, and should not be considered a therapeutic target[4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MT-CO3 pseudogene 13 (MTCO3P13).